Skip to main content

Table 1 Demographic data and diagnostic test results of the 50 enrolled patients

From: Expression of 5-hydroxytryptamine 7 receptor in intestinal mucosa correlates with the degree of intestinal inflammation in Crohn’s disease

Characteristics

control group

remission group

active group

Age (Years), Mean ± SD

31.15 ± 5.89

27.09 ± 6.59

27.54 ± 6.44

Gender, n (%)

   

Male

9(45.0%)

17(53.1%)

15(53.6%)

Female

11(55.0%)

15(46.9%)

13(46.4%)

Course (Years), Mean ± SD

 

3.65 ± 2.45

3.96 ± 2.44

Location

   

Ileum, n (%)

 

2(6.2%)

1(3.6%)

Ileocolon, n (%)

 

18(56.3%)

22(78.6%)

Colon, n(%)

 

12(37.5%)

5(17.8%)

Classification

   

Penetrating, n(%)

 

5(15.6%)

7(25.0%)

Stricturing, n(%)

 

21(65.6%)

16(57.2%)

Non-stricturing & non-penetrating, n(%)

 

6(18.8%)

5(17.8%)

Perianally lesions, n(%)

 

3(9.4%)

6(21.4%)

Operation history, n(%)

 

5(16.6%)

9(32.1%)

Smoking history, n(%)

2(10.0%)

4(12.5%)

6(21.4%)

Best CDAI Score, Mean ± SD

19.35 ± 10.97

102.09 ± 28.79

329.83 ± 108.69

SES-CD Score, Mean ± SD

1.45 ± 0.94

15.07 ± 3.26

6.43 ± 1.68

MaRIA Score, Mean ± SD

3.51 ± 1.86

12.14 ± 1.22

49.77 ± 13.46

Laboratory tests

   

ESR (mm/h) ,Mean ± SD

5.60 ± 2.11

15.01 ± 4.80

36.50 ± 8.22

CRP (mg/L), Mean ± SD

6.25 ± 2.24

23.03 ± 4.76

65.85 ± 14.12

WBC (×109/L), Mean ± SD

6.43 ± 1.28

8.72 ± 1.21

13.95 ± 1.65

HB (g/L), Mean ± SD

132.95 ± 9.13

95.73 ± 9.58

70.60 ± 9.46

HCT (%), Mean ± SD

40.17 ± 2.97

34.17 ± 2.84

29.29 ± 1.95

ALB (g/L), Mean ± SD

47.77 ± 4.64

35.71 ± 2.81

28.45 ± 2.12